Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives
Tom G. Richardson, Qin Wang, Eleanor C. M. Sanderson, Anubha Mahajan, Mark I. McCarthy, Timothy M. Frayling, Mika Ala‐Korpela, Allan D. Sniderman, George Davey Smith, Michael Vaclav Holmes
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1016/s2666-7568(21)00086-6 ↗
- Volume · Issue · Pages
- 2 · 6 · e317-e326
- Publisher
- Elsevier Ltd.
- Article URL
- https://doi.org/10.1016/s2666-7568(21)00086-6 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
20 May 2021
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 20 May 2021 | OpenAlex |
Keywords (as given): apolipoprotein B; lifespan; type 2 diabetes; coronary artery disease; stroke; hypertension; LDL cholesterol; triglycerides; lipoprotein lipids; first-degree relatives; causal effects; genetic instruments; age at death
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Lancet Healthy Longevity, The
- Publication date used
- 20 May 2021 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.